「nov」の検索結果
23件：6～10件目を表示
-
千寿製薬株式会社
in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufact...
http://www.senju.co.jp/english/ -
. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
, Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. (Headquar...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
千寿製薬株式会社
3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing ...
https://www.senju.co.jp/chinese/